Loading…

Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort

Diabetes mellitus affects 422 million people around the world, positioning it as a major health problem. According to the WHO(World Health Organization), 90% corresponds to type 2. The shared-decision making (SDM) is a method used to facilitate patient control, medication, maintenance, and assessmen...

Full description

Saved in:
Bibliographic Details
Published in:Medicina (Kaunas, Lithuania) Lithuania), 2022-03, Vol.58 (3), p.380
Main Authors: Farfán Bajaña, María José, Moncayo-Rizzo, Jorge, Alvarado-Villa, Geovanny, Avila-Quintero, Victor J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c443t-b54b2340014bb1cb8ed913ce6e6d59bdb013c78c53fbf8ac1714d115c298c0ee3
container_end_page
container_issue 3
container_start_page 380
container_title Medicina (Kaunas, Lithuania)
container_volume 58
creator Farfán Bajaña, María José
Moncayo-Rizzo, Jorge
Alvarado-Villa, Geovanny
Avila-Quintero, Victor J
description Diabetes mellitus affects 422 million people around the world, positioning it as a major health problem. According to the WHO(World Health Organization), 90% corresponds to type 2. The shared-decision making (SDM) is a method used to facilitate patient control, medication, maintenance, and assessment of health status according to their priorities and preferences. With the application of SDM in patients with diabetes, it is expected there will be an increase in treatment adherence and a reduction in HbA1c levels. The aim of this study is to determine the predictors of the change in HbA1c. A sample of 76 participants attending as endocrinology outpatients was obtained. Data collected within the sample included: sex, age, educational level, body mass index, and the level of SDM using the SDMQ-9. In addition, HbA1c levels were measured twice: at baseline and three months after the first measurement. The linear regression indicates that the level of SDM is a significant predictor of the change in HbA1c, specifically in men. However, the direction of the relationship was a somewhat opposite trend than we expected. Higher levels of SDM imply an increase in HbA1c rather than a reduction. : Contrary to the literature, our results shows that elevated levels of perceived SDM may be associated with worse diabetic control. However, more investigation is needed as these results are not generalizable, due to the specific population used and the sample size. Furthermore, to better understand the effect of SDM on the change in HbA1c in patients with poorly controlled diabetes.
doi_str_mv 10.3390/medicina58030380
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_42155973c99c4d3dad4d7915186c8088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_42155973c99c4d3dad4d7915186c8088</doaj_id><sourcerecordid>2644013329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-b54b2340014bb1cb8ed913ce6e6d59bdb013c78c53fbf8ac1714d115c298c0ee3</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhi0EoiVw54QsceGyYO_Yu_YFFKXphxQECDhb_kriaGO39m4l_j0OKVXb03g87zyamReht5R8BJDk0967YEPUXBAgIMgzdEo7JhpJGXv-4H2CXpWyIwRa3rcv0QlwAMZ5d4qWZ8kXPG49_nn29Ucj8fd8YI54sdVxU0sh4kszpxav_K0fyhc8j3hpJ-1SDjriRdqmPL5GL9Z6KP7NXZyh3-fLX4vLZvXt4moxXzWWMRgbw5lpgRFCmTHUGuGdpGB95zvHpXGG1KwXlsParIW2tKfMUcptK4Ul3sMMXR25Lumdus5hr_MflXRQ_z5S3iidx2AHr1hLOZc9WCktc-C0Y66XlFPRWUGEqKzPR9b1ZOodrY9j1sMj6ONKDFu1SbdKSE5knXuGPtwBcrqZfBnVPhTrh0FHn6ai2o6xuhC0skrfP5Hu0pRjPdVB1XIOHTuoyFFlcyol-_X9MJSog9_qqd-15d3DJe4b_hsMfwFvRKUC</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2642553649</pqid></control><display><type>article</type><title>Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Farfán Bajaña, María José ; Moncayo-Rizzo, Jorge ; Alvarado-Villa, Geovanny ; Avila-Quintero, Victor J</creator><creatorcontrib>Farfán Bajaña, María José ; Moncayo-Rizzo, Jorge ; Alvarado-Villa, Geovanny ; Avila-Quintero, Victor J</creatorcontrib><description>Diabetes mellitus affects 422 million people around the world, positioning it as a major health problem. According to the WHO(World Health Organization), 90% corresponds to type 2. The shared-decision making (SDM) is a method used to facilitate patient control, medication, maintenance, and assessment of health status according to their priorities and preferences. With the application of SDM in patients with diabetes, it is expected there will be an increase in treatment adherence and a reduction in HbA1c levels. The aim of this study is to determine the predictors of the change in HbA1c. A sample of 76 participants attending as endocrinology outpatients was obtained. Data collected within the sample included: sex, age, educational level, body mass index, and the level of SDM using the SDMQ-9. In addition, HbA1c levels were measured twice: at baseline and three months after the first measurement. The linear regression indicates that the level of SDM is a significant predictor of the change in HbA1c, specifically in men. However, the direction of the relationship was a somewhat opposite trend than we expected. Higher levels of SDM imply an increase in HbA1c rather than a reduction. : Contrary to the literature, our results shows that elevated levels of perceived SDM may be associated with worse diabetic control. However, more investigation is needed as these results are not generalizable, due to the specific population used and the sample size. Furthermore, to better understand the effect of SDM on the change in HbA1c in patients with poorly controlled diabetes.</description><identifier>ISSN: 1648-9144</identifier><identifier>ISSN: 1010-660X</identifier><identifier>EISSN: 1648-9144</identifier><identifier>DOI: 10.3390/medicina58030380</identifier><identifier>PMID: 35334556</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Body mass index ; Clinical decision making ; Decision Making ; Diabetes ; Diabetes Mellitus ; diabetes mellitus type 2 ; Disease ; Ecuador - epidemiology ; Endocrinology ; Glucose ; Glycated Hemoglobin ; glycosylated hemoglobin ; Hemoglobin ; Humans ; Laboratories ; Male ; Overweight ; Patients ; Questionnaires ; Racial Groups ; Regression analysis ; SDMQ-9 ; shared decision making ; Variables</subject><ispartof>Medicina (Kaunas, Lithuania), 2022-03, Vol.58 (3), p.380</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c443t-b54b2340014bb1cb8ed913ce6e6d59bdb013c78c53fbf8ac1714d115c298c0ee3</cites><orcidid>0000-0001-5928-9812 ; 0000-0001-5699-9819 ; 0000-0002-9231-4503 ; 0000-0002-9099-4410</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2642553649/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2642553649?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35334556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Farfán Bajaña, María José</creatorcontrib><creatorcontrib>Moncayo-Rizzo, Jorge</creatorcontrib><creatorcontrib>Alvarado-Villa, Geovanny</creatorcontrib><creatorcontrib>Avila-Quintero, Victor J</creatorcontrib><title>Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort</title><title>Medicina (Kaunas, Lithuania)</title><addtitle>Medicina (Kaunas)</addtitle><description>Diabetes mellitus affects 422 million people around the world, positioning it as a major health problem. According to the WHO(World Health Organization), 90% corresponds to type 2. The shared-decision making (SDM) is a method used to facilitate patient control, medication, maintenance, and assessment of health status according to their priorities and preferences. With the application of SDM in patients with diabetes, it is expected there will be an increase in treatment adherence and a reduction in HbA1c levels. The aim of this study is to determine the predictors of the change in HbA1c. A sample of 76 participants attending as endocrinology outpatients was obtained. Data collected within the sample included: sex, age, educational level, body mass index, and the level of SDM using the SDMQ-9. In addition, HbA1c levels were measured twice: at baseline and three months after the first measurement. The linear regression indicates that the level of SDM is a significant predictor of the change in HbA1c, specifically in men. However, the direction of the relationship was a somewhat opposite trend than we expected. Higher levels of SDM imply an increase in HbA1c rather than a reduction. : Contrary to the literature, our results shows that elevated levels of perceived SDM may be associated with worse diabetic control. However, more investigation is needed as these results are not generalizable, due to the specific population used and the sample size. Furthermore, to better understand the effect of SDM on the change in HbA1c in patients with poorly controlled diabetes.</description><subject>Body mass index</subject><subject>Clinical decision making</subject><subject>Decision Making</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>diabetes mellitus type 2</subject><subject>Disease</subject><subject>Ecuador - epidemiology</subject><subject>Endocrinology</subject><subject>Glucose</subject><subject>Glycated Hemoglobin</subject><subject>glycosylated hemoglobin</subject><subject>Hemoglobin</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Male</subject><subject>Overweight</subject><subject>Patients</subject><subject>Questionnaires</subject><subject>Racial Groups</subject><subject>Regression analysis</subject><subject>SDMQ-9</subject><subject>shared decision making</subject><subject>Variables</subject><issn>1648-9144</issn><issn>1010-660X</issn><issn>1648-9144</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1vEzEQhi0EoiVw54QsceGyYO_Yu_YFFKXphxQECDhb_kriaGO39m4l_j0OKVXb03g87zyamReht5R8BJDk0967YEPUXBAgIMgzdEo7JhpJGXv-4H2CXpWyIwRa3rcv0QlwAMZ5d4qWZ8kXPG49_nn29Ucj8fd8YI54sdVxU0sh4kszpxav_K0fyhc8j3hpJ-1SDjriRdqmPL5GL9Z6KP7NXZyh3-fLX4vLZvXt4moxXzWWMRgbw5lpgRFCmTHUGuGdpGB95zvHpXGG1KwXlsParIW2tKfMUcptK4Ul3sMMXR25Lumdus5hr_MflXRQ_z5S3iidx2AHr1hLOZc9WCktc-C0Y66XlFPRWUGEqKzPR9b1ZOodrY9j1sMj6ONKDFu1SbdKSE5knXuGPtwBcrqZfBnVPhTrh0FHn6ai2o6xuhC0skrfP5Hu0pRjPdVB1XIOHTuoyFFlcyol-_X9MJSog9_qqd-15d3DJe4b_hsMfwFvRKUC</recordid><startdate>20220304</startdate><enddate>20220304</enddate><creator>Farfán Bajaña, María José</creator><creator>Moncayo-Rizzo, Jorge</creator><creator>Alvarado-Villa, Geovanny</creator><creator>Avila-Quintero, Victor J</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5928-9812</orcidid><orcidid>https://orcid.org/0000-0001-5699-9819</orcidid><orcidid>https://orcid.org/0000-0002-9231-4503</orcidid><orcidid>https://orcid.org/0000-0002-9099-4410</orcidid></search><sort><creationdate>20220304</creationdate><title>Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort</title><author>Farfán Bajaña, María José ; Moncayo-Rizzo, Jorge ; Alvarado-Villa, Geovanny ; Avila-Quintero, Victor J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-b54b2340014bb1cb8ed913ce6e6d59bdb013c78c53fbf8ac1714d115c298c0ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Body mass index</topic><topic>Clinical decision making</topic><topic>Decision Making</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>diabetes mellitus type 2</topic><topic>Disease</topic><topic>Ecuador - epidemiology</topic><topic>Endocrinology</topic><topic>Glucose</topic><topic>Glycated Hemoglobin</topic><topic>glycosylated hemoglobin</topic><topic>Hemoglobin</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Male</topic><topic>Overweight</topic><topic>Patients</topic><topic>Questionnaires</topic><topic>Racial Groups</topic><topic>Regression analysis</topic><topic>SDMQ-9</topic><topic>shared decision making</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farfán Bajaña, María José</creatorcontrib><creatorcontrib>Moncayo-Rizzo, Jorge</creatorcontrib><creatorcontrib>Alvarado-Villa, Geovanny</creatorcontrib><creatorcontrib>Avila-Quintero, Victor J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Medicina (Kaunas, Lithuania)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farfán Bajaña, María José</au><au>Moncayo-Rizzo, Jorge</au><au>Alvarado-Villa, Geovanny</au><au>Avila-Quintero, Victor J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort</atitle><jtitle>Medicina (Kaunas, Lithuania)</jtitle><addtitle>Medicina (Kaunas)</addtitle><date>2022-03-04</date><risdate>2022</risdate><volume>58</volume><issue>3</issue><spage>380</spage><pages>380-</pages><issn>1648-9144</issn><issn>1010-660X</issn><eissn>1648-9144</eissn><abstract>Diabetes mellitus affects 422 million people around the world, positioning it as a major health problem. According to the WHO(World Health Organization), 90% corresponds to type 2. The shared-decision making (SDM) is a method used to facilitate patient control, medication, maintenance, and assessment of health status according to their priorities and preferences. With the application of SDM in patients with diabetes, it is expected there will be an increase in treatment adherence and a reduction in HbA1c levels. The aim of this study is to determine the predictors of the change in HbA1c. A sample of 76 participants attending as endocrinology outpatients was obtained. Data collected within the sample included: sex, age, educational level, body mass index, and the level of SDM using the SDMQ-9. In addition, HbA1c levels were measured twice: at baseline and three months after the first measurement. The linear regression indicates that the level of SDM is a significant predictor of the change in HbA1c, specifically in men. However, the direction of the relationship was a somewhat opposite trend than we expected. Higher levels of SDM imply an increase in HbA1c rather than a reduction. : Contrary to the literature, our results shows that elevated levels of perceived SDM may be associated with worse diabetic control. However, more investigation is needed as these results are not generalizable, due to the specific population used and the sample size. Furthermore, to better understand the effect of SDM on the change in HbA1c in patients with poorly controlled diabetes.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35334556</pmid><doi>10.3390/medicina58030380</doi><orcidid>https://orcid.org/0000-0001-5928-9812</orcidid><orcidid>https://orcid.org/0000-0001-5699-9819</orcidid><orcidid>https://orcid.org/0000-0002-9231-4503</orcidid><orcidid>https://orcid.org/0000-0002-9099-4410</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1648-9144
ispartof Medicina (Kaunas, Lithuania), 2022-03, Vol.58 (3), p.380
issn 1648-9144
1010-660X
1648-9144
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_42155973c99c4d3dad4d7915186c8088
source Publicly Available Content (ProQuest); PubMed Central
subjects Body mass index
Clinical decision making
Decision Making
Diabetes
Diabetes Mellitus
diabetes mellitus type 2
Disease
Ecuador - epidemiology
Endocrinology
Glucose
Glycated Hemoglobin
glycosylated hemoglobin
Hemoglobin
Humans
Laboratories
Male
Overweight
Patients
Questionnaires
Racial Groups
Regression analysis
SDMQ-9
shared decision making
Variables
title Does the SDMQ-9 Predict Changes in HbA1c Levels? An Ecuadorian Cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A43%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20the%20SDMQ-9%20Predict%20Changes%20in%20HbA1c%20Levels?%20An%20Ecuadorian%20Cohort&rft.jtitle=Medicina%20(Kaunas,%20Lithuania)&rft.au=Farf%C3%A1n%20Baja%C3%B1a,%20Mar%C3%ADa%20Jos%C3%A9&rft.date=2022-03-04&rft.volume=58&rft.issue=3&rft.spage=380&rft.pages=380-&rft.issn=1648-9144&rft.eissn=1648-9144&rft_id=info:doi/10.3390/medicina58030380&rft_dat=%3Cproquest_doaj_%3E2644013329%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-b54b2340014bb1cb8ed913ce6e6d59bdb013c78c53fbf8ac1714d115c298c0ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2642553649&rft_id=info:pmid/35334556&rfr_iscdi=true